Analysis Of Income And Expense [Abstract]

Marinomed Biotech AG - Filing #1129987

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	—	8,124 EUR	—	—	—	—	6,145 EUR
Material income and expense [abstract]
Finance income (cost)	—	—	1,907,000 EUR	—	—	—	—	1,002 EUR
Expenses by nature [abstract]
Raw materials and consumables used	—	—	5,414 EUR	—	—	—	—	3,575 EUR
Services expense	—	—	3,352 EUR	—	—	—	—	3,082 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense	—	—	4,098 EUR	—	—	—	—	4,219 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	—	—	4,284,000 EUR	—	—	—	—	3,272,000 EUR
Other expenses, by nature	—	—	1,793 EUR	—	—	—	—	1,833 EUR
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	6,010 EUR	- EUR	6,010 EUR	- EUR	- EUR	- EUR	7,216 EUR	7,216 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	—	6,010 EUR	—	—	—	—	7,216 EUR